WORTZMAN MARILYN E 4
4 · Transcept Pharmaceuticals Inc · Filed Oct 5, 2011
Insider Transaction Report
Form 4
WORTZMAN MARILYN E
VP, Finance
Transactions
- Sale
Common Stock
2011-10-04$8.00/sh−4,000$32,000→ 217 total - Exercise/Conversion
Common Stock
2011-10-04$1.77/sh+4,000$7,075→ 4,217 total - Exercise/Conversion
Employee Stock Option (right to buy)
2011-10-04−4,000→ 4,027 totalExercise: $1.77Exp: 2017-04-04→ Common Stock (4,000 underlying)
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2010.
- [F2]One-fourth of the shares subject to the option vested on March 16, 2008 and one forty-eighth of the shares shall vest monthly thereafter.